Oventus Medical Limited reported consolidated earnings results for the half year ended December 31, 2017. For the period, the company reported sales revenue of AUD 135,736 against AUD 255,236 a year ago. Operating loss before interest and tax was AUD 2,836,991 against AUD 3,044,668 a year ago. Loss before income tax expense was AUD 2,769,815 against AUD 2,997,170 a year ago. Loss for the half-year attributable to owners of the Company was AUD 2,769,815 against AUD 2,997,170 a year ago. Diluted loss per share was 3.00 cents against 4.31 cent a year ago. Net cash outflow from operating activities was AUD 2,948,527 against AUD 3,053,466 a year ago. Payments for property, plant and equipment was AUD 49,732 against AUD 204,771 a year ago. Payments for intangible assets were AUD 675,078 against AUD 1,173,616 a year ago. Net tangible assets per ordinary security were 14.57 cents against 11.27 cents a year ago.